Maeve O'Meara - 26 Dec 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Maeve O'Meara
Issuer symbol
TOI
Transactions as of
26 Dec 2023
Net transactions value
$0
Form type
4
Filing time
28 Dec 2023, 16:58:10 UTC
Previous filing
21 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +50,000 +85% $0.000000 109,104 26 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.